皮肤病药物全球市场规模调查和预测，按适应症（痤疮、牛皮癣、酒渣鼻、脱髮等），区域分析，2022-2029 年

2021 年全球皮肤病治疗市场价值约为 170 亿美元，预计在 2022-2029 年预测期内将以超过 10.8% 的健康增长率增长。

皮肤科药物是用于治疗各种皮肤病的药物物质，其直接关注的是皮肤护理。 各种皮肤病，如痤疮、斑秃、天疱疮，都是用皮肤科药物治疗的。 皮肤病学治疗的重点是治疗和预防皮肤病。 推动市场增长的因素包括对皮肤病的研究、对皮肤病认识的提高、对创新产品的需求增加、治疗药物的批准、研发投资的增加以及可支配收入的增加。它是

根据 Health, Pharma & MedTech 的数据，到 2021 年，大约 23% 的印度受访者将患有痤疮和头皮屑等皮肤病。 根据美国皮肤病学会的数据，大约 85% 的 12 至 24 岁成年人患有轻度痤疮。 皮肤病的日益流行推动了皮肤病药物市场的增长。 此外，2023年全球护肤品市场规模约为187.1亿日元，其中大部分将发生在美国。 皮肤病治疗的增加表明人们对皮肤病的认识不断提高，推动了市场增长。 推动市场扩张的其他关键因素包括对创新产品的需求增加、治疗药物的批准、研发投资的增加以及可支配收入的增加。 此外，医疗保健支出的增加和製药行业的扩张是创造重要市场机会的因素。 然而，替代品的可用性阻碍了整个 2022-2029 年预测期内的市场增长。

全球皮肤病治疗市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 欧洲有大量皮肤病患者，正在推进地下储氢，政府加大对发展储氢设施的投资，加大对医疗保健领域的投资，该地区的氢能源在市场上占据主导地位因投资增加而产生的收益 由于技术进步、实时数据传输、天然气部署意识增强以及对政府法规的支持等因素，预计北美在预测期内将以最高复合年增长率增长。

内容

第 1 章执行摘要

• 市场概况
• 2019-2029 年全球和细分市场估计和预测
  • 2019-2029 年按地区划分的皮肤病药物市场
  • 皮肤病药物市场，按适应症，2019-2029 年
• 主要趋势
• 调查方法
• 调查先决条件

第 2 章。全球皮肤病治疗市场的定义和范围

• 调查目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 本次调查涵盖的年份
• 货币兑换率

第3章全球皮肤病药物市场动态

• 皮肤科药物市场影响分析 (2019-2029)
  • 市场驱动因素
    • 增加粗糙皮肤
    • 提高对皮肤病的认识
  • 市场挑战
    • 备选方案的可用性
  • 市场机会
    • 不断上涨的医疗费用
    • 医药行业的发展

第 4 章全球皮肤病治疗市场：行业分析

• 波特 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 波特 5 力模型的未来方法 (2019-2029)
• 害虫分析
  • 政治
  • 经济的
  • 社交
  • 技术
• 投资招聘模式
• 分析师的建议和结论
• 主要投资机会
• 关键成功策略

第 5 章风险评估：COVID-19 的影响

• 评估 COVID-19 对行业的总体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球皮肤科市场：按适应症分类

• 市场概况
• 全球皮肤病药物市场：按适应症、按性能 - 潜力分析
• 2019-2029 年全球皮肤病药物市场的适应症估计和预测
• 皮肤科药物市场、细分市场分析
  • 痤疮
  • 银屑病
  • 酒渣鼻
  • 脱髮
  • 其他

第 7 章。全球皮肤病药物市场：区域分析

• 皮肤病治疗市场：按地区划分的市场概况
• 北美
  • 美国
    • 2019-2029 年各适应症的估计和预测
  • 加拿大
• 欧洲皮肤病药物市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲
• 亚太地区皮肤病治疗市场概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲皮肤病药物市场概况
  • 巴西
  • 墨西哥
• 世界其他地方

第 8 章衝突信息

• 顶级市场策略
• 公司简介
  • 诺华公司
    • 关键信息
    • 概览
    • 财务（仅当数据可用时）
    • 产品概览
    • 近期趋势
  • Amgen Inc
  • AbbVie Inc
  • Johnson & Johnson Private Limited
  • Leo Pharma A/S
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • AstraZeneca plc
  • Pfizer Inc
  • Merck KGaA

第九章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场评估
  • 验证
  • 出版
• 调查的特点
• 调查先决条件

Global Dermatological Drugs Market is valued at approximately USD 17.0 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.8% over the forecast period 2022-2029. Dermatological drugs are medical substances used to treat a variety of skin disorders and their direct concern is skin care. Various skin disorders such as Acne, Alopecia Areata, Pemphigus, and more are treated through dermatological drugs. The focus of Dermatological drugs is to cure and prevent skin disorders. Increasing skin conditions, growing awareness regarding skin diseases, increasing demand for innovative products, approval of drugs for treatment, increasing investment in research and development, and increasing disposable income are the factors driving the growth of the market.

According to Health, Pharma & MedTech, in India, around 23% of the respondents suffered from skin conditions such as acne and dandruff in 2021. According to the American Academy of Dermatology Association, around 85% of adult people aged between 12 to 24 experience minor acne. The increasing prevalence of skin conditions results in the growth of the dermatological drugs market. Additionally, the global skin treatment in 2023 was valued at around 18.71 billion, most of which is generated in the US. Increasing treatment of skin conditions shows the increasing awareness of skin diseases which drives the market growth. Other important components driving market increase are increasing demand for innovative products, approval of drugs for treatment, increasing investment in research and development, and increasing disposable income. Furthermore, an increase in healthcare expenditure and the Development of the pharmaceutical industry are the factors creating major market opportunities. However, the availability of alternatives stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Dermatological Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Europe dominated the market in terms of revenue, owing to the high number of patients with skin diseases, increasing underground hydrogen storage adoption, increasing government investment in the development of hydrogen storage capacities, rising investments in the healthcare sector, and the region's increasing investment in hydrogen energy. North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as technological advancements, real-time data delivery, Increasing awareness regarding the adoption of natural gas and, supportive government regulations

Major market players included in this report are:

• Novartis AG
• Amgen Inc
• AbbVie Inc
• Johnson & Johnson Private Limited
• Leo Pharma A/S
• Eli Lilly and Company
• GlaxoSmithKline Plc
• AstraZeneca plc
• Pfizer Inc
• Merck KGaA

Recent Developments in the Market:

• In July 2021, TWYNEO cream of Sol-Gel Technologies Ltd was approved by US FDA for the treatment of acne vulgaris.
• In June 2021, Kyowa Kirin Co., Ltd. and Amgen have agreed to work together to develop and market KHK4083 for the treatment of skin diseases such as atopic dermatitis.

Global Dermatological Drugs Market Report Scope:

• Historical Data 2019-2020-2021

• Base Year for Estimation 2021

• Forecast period 2022-2029

• Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered Indication, Region

• Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Indication offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Indication:

• Acne
• Psoriasis
• Rosacea
• Alopecia
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Dermatological Drugs Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Dermatological Drugs Market, by Indication, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Dermatological Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Dermatological Drugs Market Dynamics

• 3.1. Dermatological Drugs Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing skin conditions
    • 3.1.1.2. Growing awareness regarding skin diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. Availability of alternatives
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increase in healthcare expenditure
    • 3.1.3.2. Development of the pharmaceutical industry

Chapter 4. Global Dermatological Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Dermatological Drugs Market, by Indication

• 6.1. Market Snapshot
• 6.2. Global Dermatological Drugs Market by Indication, Performance - Potential Analysis
• 6.3. Global Dermatological Drugs Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
• 6.4. Dermatological Drugs Market, Sub Segment Analysis
  • 6.4.1. Acne
  • 6.4.2. Psoriasis
  • 6.4.3. Rosacea
  • 6.4.4. Alopecia
  • 6.4.5. Others

Chapter 7. Global Dermatological Drugs Market, Regional Analysis

• 7.1. Dermatological Drugs Market, Regional Market Snapshot
• 7.2. North America Dermatological Drugs Market
  • 7.2.1. U.S. Dermatological Drugs Market
    • 7.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
  • 7.2.2. Canada Dermatological Drugs Market
• 7.3. Europe Dermatological Drugs Market Snapshot
  • 7.3.1. U.K. Dermatological Drugs Market
  • 7.3.2. Germany Dermatological Drugs Market
  • 7.3.3. France Dermatological Drugs Market
  • 7.3.4. Spain Dermatological Drugs Market
  • 7.3.5. Italy Dermatological Drugs Market
  • 7.3.6. Rest of Europe Dermatological Drugs Market
• 7.4. Asia-Pacific Dermatological Drugs Market Snapshot
  • 7.4.1. China Dermatological Drugs Market
  • 7.4.2. India Dermatological Drugs Market
  • 7.4.3. Japan Dermatological Drugs Market
  • 7.4.4. Australia Dermatological Drugs Market
  • 7.4.5. South Korea Dermatological Drugs Market
  • 7.4.6. Rest of Asia Pacific Dermatological Drugs Market
• 7.5. Latin America Dermatological Drugs Market Snapshot
  • 7.5.1. Brazil Dermatological Drugs Market
  • 7.5.2. Mexico Dermatological Drugs Market
• 7.6. Rest of The World Dermatological Drugs Market

Chapter 8. Competitive Intelligence

• 8.1. Top Market Strategies
• 8.2. Company Profiles
  • 8.2.1. Novartis AG
    • 8.2.1.1. Key Information
    • 8.2.1.2. Overview
    • 8.2.1.3. Financial (Subject to Data Availability)
    • 8.2.1.4. Product Summary
    • 8.2.1.5. Recent Developments
  • 8.2.2. Amgen Inc
  • 8.2.3. AbbVie Inc
  • 8.2.4. Johnson & Johnson Private Limited
  • 8.2.5. Leo Pharma A/S
  • 8.2.6. Eli Lilly and Company
  • 8.2.7. GlaxoSmithKline Plc
  • 8.2.8. AstraZeneca plc
  • 8.2.9. Pfizer Inc
  • 8.2.10. Merck KGaA

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Dermatological Drugs Market, report scope
• TABLE 2. Global Dermatological Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Dermatological Drugs Market estimates & forecasts by Indication 2019-2029 (USD Billion)
• TABLE 4. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 5. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. U.S. Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 16. U.S. Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. Canada Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. Canada Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. UK Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. UK Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. Germany Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. Germany Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. France Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 27. France Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. Italy Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 30. Italy Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Spain Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 33. Spain Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. RoE Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 36. RoE Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. China Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 39. China Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. India Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 42. India Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. Japan Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 45. Japan Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. South Korea Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 48. South Korea Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. Australia Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 51. Australia Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. RoAPAC Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. Brazil Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 57. Brazil Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Mexico Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 60. Mexico Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. RoLA Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 63. RoLA Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. Row Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 66. Row Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. List of secondary sources, used in the study of global Dermatological Drugs Market
• TABLE 69. List of primary sources, used in the study of global Dermatological Drugs Market
• TABLE 70. Years considered for the study
• TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Dermatological Drugs Market, research methodology
• FIG 2. Global Dermatological Drugs Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Dermatological Drugs Market, key trends 2021
• FIG 5. Global Dermatological Drugs Market, growth prospects 2022-2029
• FIG 6. Global Dermatological Drugs Market, porters 5 force model
• FIG 7. Global Dermatological Drugs Market, pest analysis
• FIG 8. Global Dermatological Drugs Market, value chain analysis
• FIG 9. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Dermatological Drugs Market, regional snapshot 2019 & 2029
• FIG 15. North America Dermatological Drugs Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Dermatological Drugs Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Dermatological Drugs Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Dermatological Drugs Market 2019 & 2029 (USD Billion)
• FIG 19. Global Dermatological Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable